Internal Medicine, Hematology & Oncology · Newburgh, NY
NPI
1902957384
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
611 Gidney Ave
Newburgh, NY, 12550
Phone (845) 561-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
101,893 services
Medicare patients, 2024
520
Average age 76
Drug cost, 2024
$4.7M
1,237 prescriptions
Company payments, 2025
$225
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Umangi M Patel was code J1439 (injection, ferric carboxymaltose, 1 mg), 20,250 times for 16 patients. In total Umangi M Patel billed 101,893 services in 180 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 20,250 | 16 | $0.88 | $18K |
| J1756 Injection, iron sucrose, 1 mg | Office | 8,400 | 17 | $0.17 | $1,469 |
| 36415 Venipuncture Blood Collection | Office | 2,176 | 473 | $8.65 | $19K |
| 85025 Blood Count | Office | 1,985 | 459 | $7.61 | $15K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,858 | 39 | $0.09 | $166 |
| 80053 Clinical Chemistry | Office | 1,302 | 415 | $10.34 | $13K |
| 99214 Office E&M - Established | Office | 805 | 345 | $93.36 | $75K |
| 88185 Surgical Pathology Examination | Office | 764 | 28 | $18.72 | $14K |
| 83615 Clinical Chemistry | Office | 585 | 224 | $5.92 | $3,463 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 561 | 134 | $44.32 | $25K |
| 82728 Clinical Chemistry | Office | 464 | 216 | $13.36 | $6,199 |
| 83735 Clinical Chemistry | Office | 455 | 144 | $6.56 | $2,983 |
| 84100 Clinical Chemistry | Office | 445 | 152 | $4.64 | $2,065 |
| 84550 Clinical Chemistry | Office | 437 | 143 | $4.43 | $1,936 |
| 83540 Clinical Chemistry | Office | 435 | 207 | $6.34 | $2,758 |
By year: 2022 $1.4M for 103,174 services; 2023 $1.3M for 85,784 services; 2024 $1.4M for 101,893 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,176 | 473 | $8.65 | $19K |
| 85025 Blood Count | 1,985 | 459 | $7.61 | $15K |
| 80053 Clinical Chemistry | 1,302 | 415 | $10.34 | $13K |
| 88185 Surgical Pathology Examination | 764 | 28 | $18.72 | $14K |
| 83615 Clinical Chemistry | 585 | 224 | $5.92 | $3,463 |
| 82728 Clinical Chemistry | 464 | 216 | $13.36 | $6,199 |
| 83735 Clinical Chemistry | 455 | 144 | $6.56 | $2,983 |
| 84100 Clinical Chemistry | 445 | 152 | $4.64 | $2,065 |
| 84550 Clinical Chemistry | 437 | 143 | $4.43 | $1,936 |
| 83540 Clinical Chemistry | 435 | 207 | $6.34 | $2,758 |
Medicare prescription drug claims, 2024
In 2024, the drug Umangi M Patel prescribed most often to Medicare patients was Anastrozole, with 157 prescriptions and refills. In total Umangi M Patel wrote 1,237 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 157 | 421 | 59 | $2,847 |
| Eliquis Apixaban | 145 | 223 | 40 | $126K |
| Hydroxyurea Generic | 69 | 149 | 17 | $1,310 |
| Aranesp Darbepoetin Alfa In Polysorbat | 62 | 66 | 14 | $161K |
| Akynzeo Fosnetupitant/Palonosetron | 49 | 49 | 14 | $58K |
| Procrit Epoetin Alfa | 35 | 35 | Under 11 | $69K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 31 | 31 | Under 11 | $452K |
| Tagrisso Osimertinib Mesylate | 31 | 31 | Under 11 | $518K |
| Xarelto Rivaroxaban | 28 | 48 | Under 11 | $26K |
| Somatuline Depot Lanreotide Acetate | 25 | 25 | Under 11 | $261K |
| Neulasta Onpro Pegfilgrastim | 23 | 23 | Under 11 | $174K |
| Ondansetron Odt Ondansetron | 20 | 20 | 17 | $175 |
| Acyclovir Generic | 20 | 34 | Under 11 | $378 |
| Mvasi Bevacizumab-Awwb | 20 | 20 | Under 11 | $98K |
| Dexamethasone Generic | 19 | 27 | Under 11 | $415 |
Brand drugs: 698 claims; generic drugs: 539 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Umangi M Patel $225 ($225 in general payments such as food, travel and fees) from 4 companies. The largest payer was Pfizer Inc. with $158.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.